Terence A. Kelly, Ph.D., Joins CoMentis as Senior Vice President for Discovery and Preclinical Development
SOUTH SAN FRANCISCO, CA–(Marketwire – July 12, 2010) – CoMentis, Inc., a privately held biopharmaceutical company, today announced that Terence A. Kelly, Ph.D., has joined the company as Senior Vice President for Discovery and Preclinical Development, effective immediately. Dr. Kelly joins CoMentis after nearly 20 years at Boehringer Ingelheim, a leading research-driven pharmaceutical company …

Read more on Marketwire